Summary
Objective
Gastric cancer mortality rates have been declining in Japan and Korea where gastric cancer is common, but mass screening programs are being conducted. However, this practice is difficult to implement in some countries with low gastric cancer incidence because of the expenses. Thus, the screening and following of high-risk patients should be performed at those countries where the patients entail high costs of time and money. The aim of our study is to determine the gastric cancer-related risk factors such as atrophic gastritis (AG) and intestinal metaplasia (IM), to identify high-risk patients in our region, to evaluate the relationship between the disease and Helicobacter pylori (H. pylori), as well as other risk factors and short-term results.
Patients and methods
Endoscopic, and histological biopsy results of 3096 patients, who had upper endoscopy because of upper gastrointestinal symptoms such as epigastric pain and dyspepsia, were retrospectively reviewed. All of these endoscopies had been performed between 2012 and 2014 in the endoscopy unit of our hospital.
Results
In total, 382 IM cases were found. A high correlation was observed between H. pylori positive patients and female gender (p = 0.02) and a significant association was detected between H. pylori negativity and IM (p = 0.001). While a high significant relation was revealed between female gender (p < 0.0001) and IM, a significant inverse relationship was detected between IM and AG (p = 0.001). The existence of H. pylori organism and being over the age of 40 were stated as significant risk factor for IM. After treatment of these patients, a significant decline was observed in IM.
Conclusion
Endoscopic diagnosis and histopathological verification of AG and IM, evaluating related risk factors, identifying high-risk patients, and inclusion of the individuals into treatment and screening programs are important in terms of preventive medicine.
Similar content being viewed by others
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006 Jan;14(1):21–33.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
Tepes B. Can gastric cancer be prevented? J Physiol Pharmacol. 2009;60(7):71–7.
Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, et al. Helicobacter pylori-negative gastric cancer in South Korea. incidence and clinicopathologic characteristics. Helicobacter. 2011;16(5):382–8.
Testino G. Gastric preneoplastic changes. Recenti Prog Med. 2004;95(5):239–44.
Shin CM, Kim N, Lee HS, Lee HE, Lee SH, Park YS, et al. Validation of diagnostic tests for Helicobacter pylori with regard to grade of atrophic gastritis and/or intestinal metaplasia. Helicobacter. 2009;14(6):512–9.
Yoo JY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol. 2007;41(8):751–5.
Arkkila PE, Seppälä K, Färkkilä MA, Veijola L, Sipponen P. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study. Scand J Gastroenterol. 2006;41(7):782–90.
Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia. especially in the elderly population: a long-term prospective cohort study. J Gastroenterol Hepatol. 2010;25(3):544–7.
de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter. 2007;12(1):1–15.
Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808–25
Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N. Smoking and gastric cancer. systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19(7):689–701.
Zhang Z, Xu G, Ma M, Yang J, Liu X. Dietary fiber intake reduces risk for gastric cancer. a meta-analysis. Gastroenterology. 2013;145(1):113–20.
Rokkas T, Sechopoulos P, Pistiolas D, Margantinis G, Koukoulis G. Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients. a meta-analysis. Eur J. Gastroenterol Hepatol. 2010;22(9):1128–33.
Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia. a nationwide multicenter prospective study in Korea. Gut Liver. 2013;7(3):303–10.
Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, et al. Body mass index and risk of gastric cancer. a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013;22(8):1395–408.
Eshmuratov A, Nah JC, Kim N, Lee HS, Lee HE, Lee BH, et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci. 2010;55(5):1364–75.
Kim N, Park YS, Cho SI, Lee HS, Choe G, Kim IW, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter. 2008;13(4):245–55.
Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109(1):138–43.
Kaise M, Miwa J, Tashiro J, Ohmoto Y, Morimoto S, Kato M, et al. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk. J Gastroenterol. 2011;46(6):736–45.
Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY, et al. The benefit of mass eradication of Helicobacter pylori infection. a community-based study of gastric cancer prevention. Gut. 2013;62(5):676–82.
Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter. 2007;12(2):32–8.
Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL et al; Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.
Choi IJ. Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc. 2014;47(6):497–503.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study have not been published in elsewhere or have never been presented in any national or international symposia.
Rights and permissions
About this article
Cite this article
Üçüncü, M., Kabul Gürbulak, E., Gürbulak, B. et al. Relationship between atrophic gastritis, gastric intestinal metaplasia and Helicobacter pylori on endoscopic screening of upper gastrointestinal tract and a brief review of the literature. Eur Surg 48, 99–104 (2016). https://doi.org/10.1007/s10353-015-0378-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10353-015-0378-9